Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma

Cancer

Volumn 75, Issue 6, 1995, Pages 1327-1338

  Levesque, Michael A ^a   Katsaros, Dionyssios ^b   Yu, He ^a   Zola, Paolo ^b   Sismondi, Piero ^b   Giardina, Giorgio ^b   Diamandis, Eleftherios P ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

enzyme linked immunosorbent assay; ovarian neoplasms; protein p53; survival; tumor antigens

Indexed keywords

PROTEIN P53; TUMOR ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; MIDDLE AGE; OVARIAN NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN P53; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0028898748     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19950315)75:6<1327::AID-CNCR2820750615>3.0.CO;2-P     Document Type: Article

References (51)

1. The p53 tumour suppressor gene
2. p53 mutations in human cancers
3. No room at the p53 inn
4. The tumor suppressor p53
5. Clinical applications of the p53 tumor‐suppressor gene
6. Quantification of protein in tumor cell lines, breast tissue extracts and serum with time‐resolved immunofluorometry
7. TP53 tumor suppressor gene: a model for investigating human mutagenesis
8. Mutations of the p53 gene occur in diverse tumor types
9. Genetic basis of p53 overexpression in human breast cancer
10. Overexpression and mutation of p53 in endometrial carcinoma
11. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancer
12. p53 protein accumulation and gene mutation in the progression of human prostate carcinoma
13. Cancer of the ovary
14. Allele losses on chromosome 17 in human epithelial ovarian carcinoma
15. Frequent allelic losses and mutations of the p53 gene in human ovarian cancer
16. p53 mutations in ovarian cancer: a late event?
17. High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA neuploidy
18. Detection of p53 gene mutations in human ovarian and endometrial cancers by polymerase chain reaction‐single strand conformation polymorphism analysis
19. High incidence of mutations of the p53 gene detected in ovarian tumors by the use of chemical mismatch cleavage
20. p53 mutation is a common genetic event in ovarian carcinoma
21. p53 gene mutations and protein accumulation in human ovarian cancer
22. Overexpression and mutation of p53 in epithelial ovarian cancer
23. Overexpression of the p53 protein and allele loss at 17pl3 in ovarian carcinoma
24. Spectrum of mutation and frequency of allelic deletion of the p53 gene in ovarian cancer
25. Mutation and overexpression of p53 in early‐stage epithelial ovarian cancer
26. p53 and Ki‐ras gene mutations in epithelial ovarian neoplasms
27. p53 alterations in non‐small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes
28. p53 expression and prognosis in gastric carcinoma
29. Human papilloma virus‐negative status and c‐myc gene overexpression: independent prognostic indicators of distant metastasis for early‐stage invasive cervical cancers
30. Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node‐negative breast cancer
31. Prognostic significance of p53 immunostaining in epithelial ovarian cancer
32. Prognostic significance of p53 overexpression in node negative breast cancer patients
33. Changes in definition of clinical staging for carcinoma of the cervix and ovary
34. Histological typing of ovarian tumors
35. Multiple labelling and time‐resolved fluorophores
36. Enzymatically amplified time‐resolved fluorescence immunoassay with terbium chelates
37. Ultrasensitive thyrotropin immunoassay based on enzymatically amplified time‐resolved fluorescence with a terbium chelate
38. Regression models and life tables
39. Nonparametric estimation from incomplete observations
40. Evaluation of survival data and two new rank order statistics arising in its consideration
41. An immunohistochemical analysis of the human nuclear phosphoprotein p53: new monoclonal antibodies and epitope mapping using recombinant p53
42. Comparison between p53 staining in tissue sections and p53 levels measured by an ELISA technique
43. Enzyme‐linked immunosorbant assay for p53 in gastrointestinal malignancy: comparison with immunohistochemistry
44. Detection of p53 gene mutations in human brain tumors by single‐strand conformation polymorphism analysis of polymerase chain reaction products
45. Comparative study of p53 gene and protein alterations in human astrocytic rumors
46. From gene to carcinogen: a rapidly evolving field in molecular epidemiology
47. Cell proliferation in carcinogenesis
48. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis
49. Maintenance of p53 alterations throughout stages of breast cancer progression
50. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms